CIPLA vs SUNPHARMA: Which Is Better on the Numbers?

Cipla Ltd (CIPLA) trades at ₹1415 on a P/E of 30.4, while Sun Pharmaceutical Industries Ltd (SUNPHARMA) trades at ₹1943 on a P/E of 37.9. On valuation, Cipla Ltd is cheaper on earnings (P/E 30.4 vs 37.9). This is a data comparison, not a recommendation.

Cipla Ltd

CIPLA
₹1,415.1

Sun Pharmaceutical Industries Ltd

SUNPHARMA
₹1,943

CIPLA vs SUNPHARMA - full comparison

MetricCIPLASUNPHARMA
Share price₹1,415.1₹1,943
P/E ratio (lower = cheaper)30.4037.90
ROE (higher = better)11.60%16.00%
ROCE (higher = better)15.50%20.50%
Dividend yield0.91%0.82%
Annualised return (history)-2.6%+10.2%
Volatility (lower = steadier)22%20%
1-year forecast (Monte Carlo median)₹1,345.1₹2,112.35
Cheapest MTF margin22% (Dhan)22% (Dhan)

Forecast as of 22 Jul

How CIPLA and SUNPHARMA compare

Not investment advice. This page compares publicly available metrics and a statistical forecast for information only. The 1-year forecast is a Monte Carlo projection from historical volatility, not a prediction. Do your own research or consult a SEBI-registered adviser before investing.

More stock comparisons

Related tools